ArticleCellular and molecular gastroenterology and hepatology2022
The Benevolent Bile: Bile Acids as Stimulants of Liver Regeneration.
Article in Cellular and molecular gastroenterology and hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Constitutive Androstane Receptor Regulates Bile Acid Homeostasis and Metabolism During Liver Regeneration.Cellular and molecular gastroenterology and hepatology · 2026Article
- Vitamin D Receptor Regulates Liver Regeneration After Partial Hepatectomy in Male Mice.Endocrinology · 2024Article
- Rebuttal to: The Benevolent Bile: Bile Acids as Stimulants of Liver Regeneration.Cellular and molecular gastroenterology and hepatology · 2022Article
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.